RESUMO
Other than in children diagnosed with attention deficit hyperactivity disorder (ADHD), the connection between ADHD and lipids has not been sufficiently investigated so far in adults. Blood serum lipoproteins and fatty acids (FA) composition were measured and analyzed by colorimetry and gaschromatography in eight male and seven female adults diagnosed with ADHD as well as in 15 age- and gender-matched healthy control subjects. In ADHD patients, polyunsaturated FAs [docosahexaenoic, arachidonic and dihomogammalinolenic acid (p = 0.048; 0.003; 0.012)] showed lower concentrations, while monounsaturated acids (palmitoleic and oleic acid) as well as total and LDL cholesterol showed higher concentrations (p = 0.011; 0.005). ADHD scores positively correlated with palmitoleic (R = -0.56; p = 0.032), stearic (R = 0.53; p = 0.044), eicosapentaenoic (R = 0.62; p = 0.014), docosahexaenoic (R = 0.51; p = 0.050), gammalinolenic (R = 0.62; p = 0.018) and alphalinolenic acid (R = 0.56; p = 0.031) concentration. Even though the total and LDL cholesterol concentrations in blood serum were significantly higher among the ADHD patients than in controls, none of the ADHD symptom scores were significantly associated with any of the lipoproteine measures. We could demonstrate that a lack of polyunsaturated FAs in blood serum of subjects with ADHD persists into adulthood. Furthermore, we could show that adult ADHD symptomatology positively correlates with elevated levels of saturated stearic and monounsaturated FAs.
Assuntos
Transtorno do Deficit de Atenção com Hiperatividade/sangue , Ácidos Graxos Monoinsaturados/sangue , Ácidos Graxos Insaturados/sangue , Adulto , Estudos de Casos e Controles , Feminino , Humanos , Lipoproteínas/sangue , MasculinoRESUMO
BACKGROUND/OBJECTIVES: Cognitive dysfunction is a common aspect of the spectrum of symptoms of geriatric depression. High homocysteine levels have been linked to cognitive decline in neuropsychiatric disorders. The present study investigated possible associations between cognitive impairment observed in geriatric depression and homocysteine levels. METHODS: The performance of 25 mentally healthy individuals and 40 patients with geriatric depression in terms of language processing, processing speed, concentration and attention was assessed with the Stroop Test and the d2 Test of Attention. Serum homocysteine was determined with an enzyme immunoassay. RESULTS: The performance of depressed patients was significantly worse in language processing (p = 0.001) and processing speed (p < 0.0001). Depressed patients with high levels of homocysteine performed better than patients with homocysteine concentrations Assuntos
Transtornos Cognitivos/etiologia
, Depressão/sangue
, Depressão/complicações
, Geriatria
, Homocisteína/sangue
, Idoso
, Atenção/fisiologia
, Feminino
, Humanos
, Técnicas Imunoenzimáticas/métodos
, Idioma
, Masculino
, Pessoa de Meia-Idade
, Testes Neuropsicológicos
RESUMO
Sleep disturbances belong to the most frequent symptoms of depression. Low concentrations of n-3-fatty acids might represent one determinant within that process. Therefore, the aim of the study was to examine the relationships between serum fatty acid concentrations and severity of sleep disturbances in depressives. Serum fatty acids were measured gaschromatographically in 118 depressive inpatients (51 males; 67 females; age 45.4+/-12.0 years), divided into subgroups according to three degrees of sleep disturbances (BDI-item). At admission and discharge, we found significant negative correlations between the degree of sleep disturbances and fatty acid concentrations (myristic, palmitic, palmitoleic, oleic, linoleic, eicosadienoic and docosahexaenoic acid). At both assessments palmitoleic and eicosadienoic acids had the strongest connections with sleep performance. Palmitoleic and oleic acid seem to be especially important for sleep disorders, may be due to their function as precursors of the sleep inducing oleamide. Linoleic and eicosadienoic acid could be helpful for maintaining sleep because they are precursors of the sleep mediator PGD2. In contrast to our hypothesis, there is not only a significant lack of n-3 fatty acids but also of special monoenoic and n-6 fatty acids in sleep-disturbed depressives.
Assuntos
Transtorno Depressivo/metabolismo , Ácidos Graxos/sangue , Transtornos do Sono-Vigília/etiologia , Adulto , Análise de Variância , Transtorno Depressivo/complicações , Ácidos Graxos Monoinsaturados/sangue , Ácidos Graxos Insaturados/sangue , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos do Sono-Vigília/metabolismoRESUMO
Fatty acids can influence important cellular and hormonal processes in the human body. Non-adequate contents of fatty acids, e.g., in blood, can cause and/or result in various diseases. In depressive patients, changes in fatty acid concentrations were found (deficits in omega3-fatty acids, in particular). This paper poses the question whether there are any relations between psychophysiological parameters and changes in fatty acid compositions. The concentration of fatty acids in serum of 118 psychiatric inpatients measured directly before and after experimentally induced stress of about 1h were analysed in relation to psychophysiological parameters continuously registered during the experimental sessions at admission, discharge and at 3 months follow-up. Systolic and diastolic blood pressure, finger pulse amplitude, forehead temperature (FD) and the EMG activity of the musculus zygomaticus consistently correlated with concentrations of single unsaturated oleic (18:1n-9) and erucic acid (22:1) and saturated myristic (14:0) and lauric acid (12:0). Negative relations were found between FD and the concentration of arachidonic acid (20:4n-6) as well as of palmitoleic acid (16:1). Furthermore, the higher the concentration of the erucic acid at discharge the higher the depression score as assessed by the Beck depression inventory (BDI). High concentrations of palmitoleic acid and lauric acid were related to a low level of depression (BDI and Hamilton scores). The implications of these findings for add-on treatment regimens in depression are discussed.